Mind Medicine (MindMed) (MNMD) Short Interest Ratio & Short Volume $7.22 -0.26 (-3.48%) (As of 05:45 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends Mind Medicine (MindMed) Short Interest DataMind Medicine (MindMed) (MNMD) has a short interest of 9.71 million shares, representing 35.63% of the float (the number of shares available for trading by the public). This marks a -3.38% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.7, indicating that it would take 8.7 days of the average trading volume of 1.43 million shares to cover all short positions.Current Short Interest9,710,000 sharesPrevious Short Interest10,050,000 sharesChange Vs. Previous Month-3.38%Dollar Volume Sold Short$79.33 millionShort Interest Ratio8.7 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares73,332,000 sharesFloat Size27,250,000 sharesShort Percent of Float35.63%Today's Trading Volume1,977,476 sharesAverage Trading Volume1,429,856 sharesToday's Volume Vs. Average138% Short Selling Mind Medicine (MindMed)? Sign up to receive the latest short interest report for Mind Medicine (MindMed) and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMNMD Short Interest Over TimeMNMD Days to Cover Over TimeMNMD Percentage of Float Shorted Over Time Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Mind Medicine (MindMed) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20249,710,000 shares $79.33 million -3.4%35.6%8.7 $8.17 11/15/202410,050,000 shares $77.99 million +0.7%36.9%9.2 $7.76 10/31/20249,980,000 shares $62.87 million -2.3%36.6%10.7 $6.30 10/15/202410,210,000 shares $60.39 million -1.5%37.4%12.5 $5.92 9/30/202410,360,000 shares $58.95 million +9.6%38.0%11.8 $5.69 9/15/20249,450,000 shares $60.95 million -4.6%34.7%8.5 $6.45 Get the Latest News and Ratings for MNMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mind Medicine (MindMed) and its competitors with MarketBeat's FREE daily newsletter. 8/31/20249,910,000 shares $60.05 million +1.3%36.3%8.4 $6.06 8/15/20249,780,000 shares $62.79 million -2.0%36.0%7.3 $6.42 7/31/20249,980,000 shares $92.41 million +8.0%36.8%7.3 $9.26 7/15/20249,240,000 shares $72.26 million +25.2%34.0%6.6 $7.82 6/30/20247,380,000 shares $53.21 million +9.5%27.2%5.1 $7.21 6/15/20246,740,000 shares $52.17 million +5.6%24.6%4.4 $7.74 5/31/20246,380,000 shares $56.14 million +4.1%23.3%3.5 $8.80 5/15/20246,130,000 shares $55.60 million +1.3%22.4%2.6 $9.07 4/30/20246,050,000 shares $57.60 million -12.6%22.0%2.6 $9.52 4/15/20246,920,000 shares $67.68 million -4.3%25.7%3.2 $9.78 3/31/20247,230,000 shares $67.96 million +23.2%26.8%3.5 $9.40 3/15/20245,870,000 shares $53.83 million +39.1%21.7%3.2 $9.17 2/29/20244,220,000 shares $24.12 million +23.0%16.1%2.8 $5.72 2/15/20243,430,000 shares $15.71 million +7.5%13.2%4.9 $4.58 1/31/20243,190,000 shares $12.31 million -0.9%12.3%5.4 $3.86 1/15/20243,220,000 shares $12.75 million +2.6%12.4%5.7 $3.96 12/31/20233,140,000 shares $11.49 million +11.7%12.1%5.8 $3.66 12/15/20232,810,000 shares $9.41 million +12.9%10.6%5.5 $3.35 11/30/20232,490,000 shares $8.22 million -10.1%9.4%6.3 $3.30 11/15/20232,770,000 shares $7.17 million -3.8%10.5%7.3 $2.59 10/31/20232,880,000 shares $7.37 million -8.0%11.1%7.5 $2.56 10/15/20233,130,000 shares $8.76 million -1.9%12.1%7.3 $2.80 9/30/20233,190,000 shares $9.98 million -3.6%12.3%6 $3.13 9/15/20233,310,000 shares $13.80 million +3.8%12.8%5.7 $4.17 8/31/20233,190,000 shares $13.24 million -5.1%12.4%5.4 $4.15 8/15/20233,360,000 shares $14.11 million -1.2%13.0%5.9 $4.20 7/31/20233,400,000 shares $16.76 million +13.7%13.2%6.1 $4.93 7/15/20232,990,000 shares $11.90 million -2.3%11.6%5.9 $3.98 6/30/20233,060,000 shares $10.92 million +3.4%11.9%6 $3.57 6/15/20232,960,000 shares $10.98 million +4.6%11.1%7 $3.71 5/31/20232,830,000 shares $10.02 million -0.4%10.7%7.2 $3.54 5/15/20232,840,000 shares $8.97 million No Change10.7%7.1 $3.16 10/31/20221,700,000 shares $4.98 million +70.0%0.4%1.2 $2.93 10/15/20221,000,000 shares $2.89 million -32.0%0.3%0.7 $2.89Why is Buffett going all in on this? (Ad)Warren Buffett has increased his already massive stake in this sector by almost 30% in the past few months. Microsoft and Blackrock created a special fund worth $100 billion to boost this 'silent' bull market. Institutional investors have a combined $2.8 trillion in this sector. Despite its "bad rap", this industry stubbornly rakes in profits.Click here to learn more >>> 9/30/20221,470,000 shares $5.15 million +52.5%0.4%1.2 $3.50 9/15/2022963,800 shares $7.25 million +13.8%0.2%1.1 $7.52 8/31/2022846,700 shares $9.92 million -95.0%0.2%1.1 $11.72 8/15/202216,990,000 shares $11.89 million -9.9%4.8%1.8 $0.70 7/31/202218,850,000 shares $13.10 million +2.1%5.3%6.6 $0.69 7/15/202218,460,000 shares $12.67 million -10.2%5.2%6.3 $0.69 6/30/202220,560,000 shares $13.16 million -42.1%N/A6.7 $0.64 6/15/202235,530,000 shares $27.09 million -5.1%10.1%11.3 $0.76 5/31/202237,440,000 shares $33.87 million -1.8%10.6%14.5 $0.90 5/15/202238,140,000 shares $29.75 million +18.3%10.7%14.4 $0.78 4/30/202232,230,000 shares $25.78 million +5.4%9.0%10.5 $0.80 4/15/202230,580,000 shares $29.66 million +11.3%8.7%7.4 $0.97 3/31/202227,480,000 shares $30.50 million +2.8%7.8%6.4 $1.11 3/15/202226,720,000 shares $27.52 million -0.5%7.5%5.8 $1.03 2/28/202226,850,000 shares $32.76 million +3.2%7.5%5.6 $1.22 2/15/202226,020,000 shares $34.87 million +10.8%7.3%5.2 $1.34 1/31/202223,480,000 shares $26.30 million +30.1%6.6%4.6 $1.12 1/15/202218,050,000 shares $20.22 million +26.2%5.0%3.7 $1.12 12/31/202114,300,000 shares $19.73 million No Change4.0%3.6 $1.38 MNMD Short Interest - Frequently Asked Questions What is Mind Medicine (MindMed)'s current short interest? Short interest is the volume of Mind Medicine (MindMed) shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 9,710,000 shares of MNMD short. 35.63% of Mind Medicine (MindMed)'s shares are currently sold short. Learn More on Mind Medicine (MindMed)'s current short interest. What is a good short interest ratio for Mind Medicine (MindMed)? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MNMD shares currently have a short interest ratio of 9.0. Learn More on Mind Medicine (MindMed)'s short interest ratio. Which institutional investors are shorting Mind Medicine (MindMed)? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mind Medicine (MindMed): Wolverine Trading LLC, Walleye Capital LLC, and Crawford Fund Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Mind Medicine (MindMed)? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 35.63% of Mind Medicine (MindMed)'s floating shares are currently sold short. Is Mind Medicine (MindMed)'s short interest increasing or decreasing? Mind Medicine (MindMed) saw a decrease in short interest in the month of November. As of November 30th, there was short interest totaling 9,710,000 shares, a decrease of 3.4% from the previous total of 10,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Mind Medicine (MindMed)'s float size? Mind Medicine (MindMed) currently has issued a total of 73,332,000 shares. Some of Mind Medicine (MindMed)'s outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mind Medicine (MindMed) currently has a public float of 27,250,000 shares. How does Mind Medicine (MindMed)'s short interest compare to its competitors? 35.63% of Mind Medicine (MindMed)'s shares are currently sold short. Here is how the short interest of companies compare to Mind Medicine (MindMed): Tilray Inc (12.03%), Cronos Group Inc. (1.72%), USANA Health Sciences, Inc. (4.39%), ChromaDex Co. (4.15%), biote Corp. (2.29%), Canopy Growth Co. (9.13%), Aurora Cannabis Inc. (8.05%), MediWound Ltd. (8.64%), FitLife Brands, Inc. (0.27%), Natural Alternatives International, Inc. (0.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Mind Medicine (MindMed) stock? Short selling MNMD is an investing strategy that aims to generate trading profit from Mind Medicine (MindMed) as its price is falling. MNMD shares are trading down $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mind Medicine (MindMed)? A short squeeze for Mind Medicine (MindMed) occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MNMD, which in turn drives the price of the stock up even further. How often is Mind Medicine (MindMed)'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MNMD, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Tilray Short Interest Cronos Group Short Interest USANA Health Sciences Short Interest ChromaDex Short Interest biote Short Interest Canopy Growth Short Interest Aurora Cannabis Short Interest MediWound Short Interest FitLife Brands Short Interest Natural Alternatives International Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MNMD) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
